Parkinson disease protein 7 (PARK7) is related to the ability of mammalian sperm to undergo in vitro capacitation
dc.contributor.author
dc.date.accessioned
2021-10-13T10:51:25Z
dc.date.available
2021-10-13T10:51:25Z
dc.date.issued
2021-10-06
dc.identifier.uri
dc.description.abstract
Parkinson disease protein 7 (PARK7) is a multifunctional protein known to be involved in the regulation of sperm motility, mitochondrial function, and oxidative stress response in mammalian sperm. While ROS generation is needed to activate the downstream signaling pathways required for sperm to undergo capacitation, oxidative stress has detrimental effects for sperm cells and a precise balance between ROS levels and antioxidant activity is needed. Considering the putative antioxidant role of PARK7, the present work sought to determine whether this protein is related to the sperm ability to withstand in vitro capacitation. To this end, and using the pig as a model, semen samples were incubated in capacitation medium for 300 min; the acrosomal exocytosis was triggered by the addition of progesterone after 240 min of incubation. At each relevant time point (0, 120, 240, 250, and 300 min), sperm motility, acrosome and plasma membrane integrity, membrane lipid disorder, mitochondrial membrane potential, intracellular calcium and ROS were evaluated. In addition, localization and protein levels of PARK7 were also assessed through immunofluorescence and immunoblotting. Based on the relative content of PARK7, two groups of samples were set. As early as 120 min of incubation, sperm samples with larger PARK7 content showed higher percentages of viable and acrosome-intact sperm, lipid disorder and superoxide levels, and lower intracellular calcium levels when compared to sperm samples with lower PARK7. These data suggest that PARK7 could play a role in preventing sperm from undergoing premature capacitation, maintaining sperm viability and providing a better ability to keep ROS homeostasis, which is needed to elicit sperm capacitation. Further studies are required to elucidate the antioxidant properties of PARK7 during in vitro capacitation and acrosomal exocytosis of mammalian sperm, and the relationship between PARK7 and sperm motility
dc.description.sponsorship
This research was funded by the Ministry of Science and Innovation, Spain (AGL2017-
88329-R), Regional Government of Catalonia, Spain (2017-SGR-1229), and University of Girona
(IFUdG-2018 grant to S.R.)
dc.format.mimetype
application/pdf
dc.language.iso
eng
dc.publisher
MDPI (Multidisciplinary Digital Publishing Institute)
dc.relation.isformatof
Reproducció digital del document publicat a: https://doi.org/10.3390/ijms221910804
dc.relation.ispartof
International Journal of Molecular Sciences, 2021, vol. 22, núm. 19, p. 10804
dc.relation.ispartofseries
Articles publicats (D-B)
dc.rights
Attribution 4.0 International (CC BY 4.0)
dc.rights.uri
dc.source
Recuero, Sandra Delgado Bermúdez, Ariadna Garcia Bonavila, Estela Mateo Otero, Yentel Llavanera, Marc Yeste Oliveras, Marc 2021 Parkinson disease protein 7 (PARK7) is related to the ability of mammalian sperm to undergo in vitro capacitation International Journal of Molecular Sciences 22 19 10804
dc.subject
dc.title
Parkinson disease protein 7 (PARK7) is related to the ability of mammalian sperm to undergo in vitro capacitation
dc.type
info:eu-repo/semantics/article
dc.rights.accessRights
info:eu-repo/semantics/openAccess
dc.relation.projectID
info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/AGL2017-88329-R/ES/MEJORA DEL RENDIMIENTO REPRODUCTIVO DEL SEMEN REFRIGERADO Y CONGELADO/DESCONGELADO DE PORCINO Y BOVINO MEDIANTE EL USO DE LA FOTOESTIMULACION/
dc.type.version
info:eu-repo/semantics/publishedVersion
dc.identifier.doi
dc.identifier.idgrec
033927
dc.contributor.funder
dc.type.peerreviewed
peer-reviewed
dc.relation.FundingProgramme
dc.relation.ProjectAcronym
dc.identifier.eissn
1422-0067